Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
US Physiological Saline Market Size and Forecasts (2020 - 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Normal Saline, Hypertonic Saline, Hypotonic Saline, and Balanced Saline), Packaging Type (Flexible Bags, Plastic Bottles, and Glass Bottles), Application (Intravenous, Ophthalmology, Wound Care, Endoscopy, Skin Abrasion, and Others), Route of Administration (Intravenous and Topical), and End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others)
US$ 3,550.00
The physiological saline market was valued at US$ 2.412 billion in 2022 and is projected to reach US$ 3.910 billion by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030. The rising pr...
December 2023
132 pages
Cold Agglutinin Disease Treatment Market - 2024-2031
US$ 3,400.00
The Cold Agglutinin Disease Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight t...
December 2023
59 pages
Paget's Disease Market - 2024-2031
US$ 3,400.00
The Paget's Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
December 2023
41 pages
Idiopathic Short Stature Treatment Market - 2024-2031
US$ 3,400.00
The Idiopathic Short Stature Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
December 2023
60 pages
Idiopathic Pulmonary Fibrosis Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type (Nintedanib, Pirfenidone, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
US$ 5,190.00
Increasing Number of People Smoking Cigarettes Fuels Idiopathic Pulmonary Fibrosis Treatment Market Growth Cigarette smoking is one of the well-known risk factors for the development of idiopathic pul...
December 2023
150 pages
Osteonecrosis Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Drugs and Surgeries), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
US$ 5,190.00
The osteonecrosis treatment market size is expected to grow from US$ 0.637 billion in 2022 to US$ 1.021 billion by 2030; the market is estimated to register a CAGR of 6.08% from 2022 to 2030. Key fact...
December 2023
150 pages
Prostate Cancer Therapeutics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography
US$ 5,190.00
The prostate cancer therapeutics market is expected to grow from US$ 14.767 billion in 2022 to US$ 28.425 billion by 2030; it is anticipated to record a CAGR of 8.5% from 2022 to 2030. Prostate cancer...
December 2023
150 pages
Hospital Acquired Infection Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs, and Others), Infection Type (Urinary Tract Infections, Ventilator-Associated Pneumonia, Surgical Site Infections, Bloodstream Infections, and Other Hospital Infections), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
US$ 5,190.00
The global hospital-acquired infection treatment market is expected to reach US$ 19.978 billion in 2030 from US$ 15.099 billion in 2022. The market is estimated to grow with a CAGR of 3.6% from 2022 t...
December 2023
171 pages
Middle East and Africa Botulinum Toxin Market Size and Forecasts (2020 - 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Botox, Dysport, Xeomin, and Others), Application (Medical and Aesthetic), and End User (Specialty and Dermatology Clinics, Hospitals and Clinics, and Others)
US$ 3,550.00
The Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to grow at a CAGR of 12.8% from 2022 to...
December 2023
150 pages
Asia Pacific Pharmaceutical Packaging Market 2023
US$ 2,850.00
Pharmaceutical packaging is of paramount importance for protecting medications, ensuring patient safety, complying with regulations, providing essential information, supporting brand identity, and add...
December 2023
87 pages
Anti-Fungal Treatment Market Size, Share, and Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Route of Administration (Oral, Topical, and Parenteral), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
US$ 5,150.00
Anti-Fungal Treatment Market Size, Share, and Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Route of Administration (Oral, Topical, and Parenteral), By Indication (Derm...
December 2023
544 pages
Plasma Therapy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Source (Autologous and Allogeneic), Application (Orthopedic Conditions, Dermatology, Dental Issues, and Others), End User (Hospitals and Clinics, Research Institutes, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
US$ 5,190.00
The plasma therapy market is expected to grow from US$ 0.390 billion in 2022 to US$ 1.097 billion by 2030; the market is estimated to register a CAGR of 13.80% from 2022 to 2030. Key factors driving t...
November 2023
150 pages
Alpha-1 Antitrypsin Deficiency Therapy Market - 2024-2031
US$ 3,400.00
The Alpha-1 Antitrypsin Deficiency Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
November 2023
64 pages
Global Market for Anti-obesity Drugs
US$ 2,950.00
Report : The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with...
November 2023
67 pages
Aminoglycosides Market - 2024-2031
US$ 3,400.00
Aminoglycosides Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Aminoglycosides Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
November 2023
41 pages
Drug Discovery Services Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Process (Target Selection and Validation, Hit to Lead Identification, and Others), Type (Biology Services, Medicinal Chemistry, and Drug Metabolism and Pharmacokinetics), Molecule Type (Biologics and Small Molecules), Therapeutic Area (Cardiovascular Diseases, Oncology, Neurology, Diabetes, Respiratory Diseases, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
US$ 5,190.00
The drug discovery services market is expected to grow from US$ 19.539 billion in 2022 to US$ 56.783 billion by 2030; it is anticipated to record a CAGR of 14.3% from 2022 to 2030. Drug discovery is t...
November 2023
150 pages
Cystinosis Treatment Market - 2024-2031
US$ 3,400.00
The Cystinosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2023
46 pages
C3 Glomerulopathy Treatment Market - 2024-2031
US$ 3,400.00
The C3 Glomerulopathy Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
November 2023
53 pages
Polymyalgia Rheumatica Treatment Market - 2024-2031
US$ 3,400.00
The Polymyalgia Rheumatica Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
November 2023
58 pages
Isovaleric Acidemia Market - 2024-2031
US$ 3,400.00
The Isovaleric Acidemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
November 2023
45 pages
Asia Pacific Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
US$ 3,000.00
The Asia Pacific eye drops market is expected to grow from US$ 2,823.84 million in 2022 to US$ 4,386.59 million by 2030. It is estimated to grow at a CAGR of 5.7% from 2022 to 2030. Rising Initiative...
November 2023
96 pages
Europe Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
US$ 3,000.00
The Europe eye drops market is expected to grow from US$ 3,496.63 million in 2022 to US$ 5,093.11 million by 2030. It is estimated to grow at a CAGR of 4.8% from 2022 to 2030. High Incidence of Age-R...
November 2023
99 pages
Middle East & Africa Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
US$ 3,000.00
The Middle East & Africa eye drops market is expected to grow from US$ 424.84 million in 2022 to US$ 580.44 million by 2030. It is estimated to grow at a CAGR of 4.0% from 2022 to 2030. Changing Life...
November 2023
82 pages
North America Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
US$ 3,000.00
The North America eye drops market is expected to grow from US$ 8,030.88 million in 2022 to US$ 12,289.12 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030. Rising Prevalen...
November 2023
87 pages
South & Central America Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
US$ 3,000.00
The South & Central America eye drops market is expected to grow from US$ 1,017.09 million in 2022 to US$ 1,439.20 million by 2030. It is estimated to grow at a CAGR of 4.4% from 2022 to 2030. Rising...
November 2023
78 pages
Physiological Saline Market - 2024-2031
US$ 3,400.00
The Physiological Saline Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2023
46 pages
Shigella Vaccines Pipeline Market - 2024-2031
US$ 3,400.00
The Shigella Vaccines Pipeline Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
November 2023
52 pages
Antibiotic Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...
November 2023
100 pages
Vaccine Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...
November 2023
400 pages
Diagnostic Imaging Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...
November 2023
300 pages
